Manufacturers: Baxter healthcare corp anesthesia and critical care, Bedford laboratories div ben venue laboratories inc +1 more
Doxapram is a short acting respiratory stimulant used to treat acute respiratory insufficiency in COPD patients.
Doxapram is a short acting respiratory stimulant used to treat acute respiratory insufficiency in COPD patients.
Doxapram produces respiratory stimulation mediated through the peripheral carotid chemoreceptors. It is thought to stimulate the carotid body by inhibiting certain potassium channels.
For use as a temporary measure in hospitalized patients with acute respiratory insufficiency superimposed on chronic obstructive pulmonary disease.
4 associated conditions
